dr hyman glp 1 I was recently joined by @drtyna and @calleymeans on The Doctor’s Farmacy, where we explored both sides of using GLP-1s. We challenge the notion of treating obesity, discuss its benefits, and how our Dr. Tyler Hyman, MD |

Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF

Discover how GLP-1 receptor agonists are transforming the food value chain

Here's who is (and is not) an ideal candidate for medical weight loss:

Learn their history, when they were introduced, and why these medications are widely used today.

7.40.8 Eq/min/gkw)

Although Canada does not allow the kind and level of direct-to-consumer advertising for prescription drugs, an opinion piece in Campaign in Canada, the marketing and ad industry publication thats a sister to a U.S